Form 4: Rockwell Medical Director Mark Ravich Acquires 50,000 Shares of Common Stock

Director Mark Ravich acquired 50,000 shares of Rockwell Medical common stock on May 20, 2025, as part of a restricted stock unit vesting.

Summary

• Mark H. Ravich, a director at Rockwell Medical, Inc., acquired 50,000 shares of common stock on May 20, 2025.
• The acquisition was in the form of restricted stock units, which will vest on May 20, 2026.
• The price per share was $0.
• Following the transaction, Ravich directly owns 148,831 shares of common stock.
• Ravich also indirectly owns 1,454 shares through the Alyssa Danielle Ravich 1991 Irrevocable Trust and 818 shares through the Alexander Coleman Ravich 1991 Irrevocable Trust, for which he serves as trustee.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director, which can be seen as a slightly positive sign, but it's not a major event.

Positives

• A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock units will vest on May 20, 2026, potentially increasing Ravich's holdings further.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Monitoring such transactions can provide insights into management's sentiment about the company's performance and prospects.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Rockwell Medical, RMTI, Mark Ravich, Director, Stock Acquisition, Form 4, Restricted Stock Units, Beneficial Ownership